These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 755671)

  • 21. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring.
    Migliaccio S; Newbold RR; Bullock BC; Jefferson WJ; Sutton FG; McLachlan JA; Korach KS
    Endocrinology; 1996 May; 137(5):2118-25. PubMed ID: 8612556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THE EFFECT OF HEPARIN AND EPSILON-AMINOCAPROIC ACID ON THE COAGULATION IN HYPOTHERMIC DOGS.
    JOHANSSON BW; NILSSON IM
    Acta Physiol Scand; 1964 Mar; 60():267-77. PubMed ID: 14131840
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs.
    Monier-Faugere MC; Geng Z; Qi Q; Arnala I; Malluche HH
    J Bone Miner Res; 1996 Apr; 11(4):446-55. PubMed ID: 8992875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron deposition at mineralization fronts and osteoid formation following chronic cadmium exposure in ovariectomized rats.
    Hiratsuka H; Katsuta O; Toyota N; Tsuchitani M; Akiba T; Marumo F; Umemura T
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):348-56. PubMed ID: 9144451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of low molecular weight heparin and unfragmented heparin on induction of osteoporosis in rats.
    Mätzsch T; Bergqvist D; Hedner U; Nilsson B; Ostergaard P
    Thromb Haemost; 1990 Jun; 63(3):505-9. PubMed ID: 2169657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heparin osteoporosis : histomorphometric analysis of bone biopsy. One case (author's transl)].
    Megard M; Cuche M; Grapeloux A; Bojoly C; Meunier PJ
    Nouv Presse Med; 1982 Jan; 11(4):261-4. PubMed ID: 7058149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate.
    Bauss F; Schenk RK; Hört S; Müller-Beckmann B; Sponer G
    J Pharmacol Toxicol Methods; 2004; 50(1):25-34. PubMed ID: 15233964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled clinical trial of the use of benazepril and heparin for the treatment of chronic kidney disease in dogs.
    Tenhündfeld J; Wefstaedt P; Nolte IJ
    J Am Vet Med Assoc; 2009 Apr; 234(8):1031-7. PubMed ID: 19366333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The thrombolytic effect of heparin and a heparin-like substance, SP 54.
    Fitz Gerald DE; Szeto IL; Spero J; Lewis JH
    Thromb Diath Haemorrh; 1967 May; 17(3-4):418-22. PubMed ID: 5589298
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ; Slappendel RJ; van den Brom WE
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viscometry of circulating blood in dogs. I. Heparin injection; II. Platelet removal.
    Frasher WG; Wayland H; Meiselman HJ
    J Appl Physiol; 1968 Dec; 25(6):751-60. PubMed ID: 5727203
    [No Abstract]   [Full Text] [Related]  

  • 35. Veno-venous bypass without systemic heparinization using a centrifugal pump: a blind comparison of a heparin bonded circuit versus a non heparin bonded circuit.
    van der Hulst VP; Henny CP; Moulijn AC; Engbers G; ten Cate H; Gründeman PF; Klopper PJ
    J Cardiovasc Surg (Torino); 1989; 30(1):118-23. PubMed ID: 2925769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term extracorporeal blood bypass in dogs at low flows without systemic heparinization. Heparin-coated versus uncoated circuits.
    van der Hulst VP; Gründeman PF; Moulijn AC; Rutten PJ; Klopper PJ
    ASAIO Trans; 1991; 37(4):577-83. PubMed ID: 1768492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of enoxaparin on histomorphometric parameters of bones in rats.
    Folwarczna J; Janiec W; Gawor M; Pytlik M; Kaczmarczyk-Sedlak I; Nowińska B
    Pol J Pharmacol; 2004; 56(4):451-7. PubMed ID: 15520500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety of the aminobisphosphonate alendronate in adult dogs. II. Histomorphometric analysis of the L5 vertebrae.
    Balena R; Markatos A; Seedor JG; Gentile M; Stark C; Peter CP; Rodan GA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):277-83. PubMed ID: 8558443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiresorptive therapy for osteoporosis and bone quality].
    Kishimoto H
    Clin Calcium; 2005 Jun; 15(6):1007-11. PubMed ID: 15930715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone and soft tissue changes with oral phosphate supplements.
    Laflamme GH; Jowsey J
    J Clin Invest; 1972 Nov; 51(11):2834-40. PubMed ID: 5080411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.